The CBD industry, once predicted to become a lucrative powerhouse, has seen a significant decrease in the market in recent years due to factors such as a plummet in hemp acreage and the rise of psychoactive hemp-derived cannabinoids like delta-8. The lack of regulatory guidelines from the FDA has also contributed to the industry’s weak market, as potential investors remain hesitant to invest due to the lack of clarity. Despite the challenges, experts and business owners believe the CBD market has stabilized and is beginning to grow again. Gummies continue to be a top-selling product, followed by beverages and topicals for pain relief. There is also rising interest in smokable CBD. Overall, the CBD industry may have faced setbacks, but it is far from out of the game.